Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 724 | 2021 |
Emerging evidence for functional peptides encoded by short open reading frames SJ Andrews, JA Rothnagel Nature Reviews Genetics 15 (3), 193-204, 2014 | 611 | 2014 |
Interpretation of risk loci from genome-wide association studies of Alzheimer's disease SJ Andrews, B Fulton-Howard, A Goate The Lancet Neurology 19 (4), 326-335, 2020 | 248 | 2020 |
Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 208 | 2022 |
APOE* E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease JI Vélez, F Lopera, D Sepulveda-Falla, HR Patel, AS Johar, A Chuah, ... Molecular psychiatry 21 (7), 916-924, 2016 | 116 | 2016 |
Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis R Peters, S Yasar, CS Anderson, S Andrews, R Antikainen, H Arima, ... Neurology 94 (3), e267-e281, 2020 | 104 | 2020 |
The variant call format provides efficient and robust storage of GWAS summary statistics MS Lyon, SJ Andrews, B Elsworth, TR Gaunt, G Hemani, E Marcora Genome biology 22 (1), 32, 2021 | 103 | 2021 |
Genetic variants and functional pathways associated with resilience to Alzheimer’s disease L Dumitrescu, ER Mahoney, S Mukherjee, ML Lee, WS Bush, ... Brain 143 (8), 2561-2575, 2020 | 95 | 2020 |
Causal associations between modifiable risk factors and the Alzheimer’s phenome SJ Andrews, B Fulton‐Howard, P O’Reilly, E Marcora, AM Goate, ... Annals of Neurology, 2020 | 94* | 2020 |
A first update on mapping the human genetic architecture of COVID-19 Writing group lead Andrews Shea J. 6 Kanai Masahiro 3 Cordioli Mattia 7, ... Nature 608 (7921), E1-E10, 2022 | 84 | 2022 |
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity J Fadista, LM Kraven, J Karjalainen, SJ Andrews, F Geller, JK Baillie, ... EBioMedicine 65, 2021 | 71 | 2021 |
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease E Horgusluoglu, R Neff, WM Song, M Wang, Q Wang, M Arnold, ... Alzheimer's & Dementia 18 (6), 1260-1278, 2022 | 63 | 2022 |
Association of genetic risk factors with cognitive decline: the PATH through life project SJ Andrews, D Das, N Cherbuin, KJ Anstey, S Easteal Neurobiology of aging 41, 150-158, 2016 | 61 | 2016 |
Association of Alzheimer's genetic loci with mild behavioral impairment SJ Andrews, Z Ismail, KJ Anstey, M Mortby American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 57 | 2018 |
Association between alcohol consumption and Alzheimer's disease: A Mendelian randomization study SJ Andrews, A Goate, KJ Anstey Alzheimer's & Dementia, 2019 | 48 | 2019 |
Memory resilience to Alzheimer’s genetic risk: Sex effects in predictor profiles KL McDermott, GP McFall, SJ Andrews, KJ Anstey, RA Dixon Journals of Gerontology Series B: Psychological Sciences and Social Sciences …, 2017 | 41 | 2017 |
The complex genetic architecture of Alzheimer's disease: novel insights and future directions SJ Andrews, AE Renton, B Fulton-Howard, A Podlesny-Drabiniok, ... EBioMedicine 90, 2023 | 37 | 2023 |
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool C Romero-Molina, F Garretti, SJ Andrews, E Marcora, AM Goate Neuron 110 (21), 3513-3533, 2022 | 34 | 2022 |
Interactive Effect of APOE Genotype and Blood Pressure on Cognitive Decline: The PATH Through Life Study S Andrews, D Das, KJ Anstey, S Easteal Journal of Alzheimer's Disease 44 (4), 2015 | 33 | 2015 |
Validating the role of the Australian National University Alzheimer’s Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a … SJ Andrews, R Eramudugolla, JI Velez, N Cherbuin, S Easteal, KJ Anstey Alzheimer's Research & Therapy 9 (1), 1-12, 2017 | 30 | 2017 |